Skip to content

Pilot study of Homeopathic Treatment of Fibromyalgia Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN74040048
Enrollment
60
Registered
2007-09-28
Start date
2006-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases: Fibromyalgia Musculoskeletal Diseases Fibromyalgia

Interventions

Homeopathy referral + usual care vs usual care.

Sponsors

Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Primary Fibromyalgia diagnoses (According to American College of Rheumatologists criteria for FMS) 2. Aged 18 years old and over 3. Score of 4 or more on FIQ pain scale (score 0-10 with 10 indicating very severe pain) at initial recruitment/assessment interview

Exclusion criteria

Exclusion criteria: 1. Pain from traumatic injury or structural disease 2. Secondary Fibromyalgia 3. Rheumatoid Arthritis 4. Inflammatory Arthritis 5. Autoimmune Disease 6. Immunosuppressant Drugs 7. Current oral steroid treatment 8. Substance abuse in last year 9. Primary psychiatric diagnosis or medication prior to onset of Fibromyalgia 10. Unstable medical or psychiatric illness 11. Chronic use of sedatives 12. Pregnant or breast feeding 13. Current acupuncture treatment 14. Homeopathic treatment in the previous three months 15. Patients not fluent in English

Design outcomes

Primary

MeasureTime frame
Difference between the Fibromyalgia Impact Questionnaire (FIQ) total score (0-80 with 0 indicating no impact), at week 22, between the experimental and control groups.

Secondary

MeasureTime frame
1.Short form McGill Pain Questionnaire 2. Measure Your Medical Outcomes Profile (MYMOP) 3. FIQ Pain score 4. FIQ fatigue score 5. FIQ tiredness on awakening score 6. FIQ stiffness score 7. EQ-5D Quality of life score 8. Hospital anxiety and depression scale (HAD) 9. Tender point count (Performed by blinded assessor) 10. Medication Change Questionnaire

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026